Adaptive organoid-based precision therapy study in pancreatic cancer (ADOPT): A phase II single-arm study to evaluate the efficacy of patient-derived organoid (PDO)-directed therapy in advanced pancreatic ductal adenocarcinoma (PDAC).

Authors: Ronan Andrew McLaughlin, Nikta Feizi, Felix Beaudry, Eugenia Flores-Figueroa, Karen Ng, Wei Quan, Rachel Ding, Xuan Li, Stephanie DeLuca, Xin Wang, Raymond Woo-Jun Jang, Elena Elimova, Grainne M. O'Kane, Erica S. Tsang, Julie Wilson, Anna Dodd, Faiyaz Notta, Steven Gallinger, Jennifer J. Knox, Robert C. Grant

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps4232

Source: Full article

---

Abstract

TPS4232